Intensifying
regulatory expectations, tougher inspection system, and instant need
for patient reporting boost the adoption rate of pharmacovigilance
among pharmaceutical companies. Rise in the prevalence of acute and
chronic diseases has consequently led to an increase in the
incidences of drug consumption, thus leading to growth in the number
of adverse drug events and drug toxicity cases. Furthermore, safety
regulations, risk of high-profile safety issues, large volume of
post-market events to be reviewed along with negative media coverage
have bound the pharmaceutical players to take support of various
outsourcing services for drug monitoring.
Browse
Pharmacovigilance Market Report with Full TOC at
http://www.transparencymarketresearch.com/pharmacovigilance-market.html
Two
major outsourcing providers preferred by pharmaceutical manufacturers
for pharmacovigilance services are namely, traditional CROs (e.g.
Covance, Inc., Quintiles Transnational, INC Research, etc.) and BPOs
(e.g. Capgemini, Cognizant, Infosys Ltd., Tata Consultancy Services
Limited, etc.). Outsourcing services do not only help in cost saving,
but also support process efficiency. Pharmaceutical companies are now
entering into long-term partnerships/service agreements with CROs and
BPOs to reduce the pharmacovigilance process related expenditure,
incurred right from drug discovery to post-marketing approvals. In
addition, pharmacovigilance requires skilled resources with excellent
language skills and strong knowledge pertaining to case reporting due
to which pharmaceutical companies are opting for outsourced
pharmacovigilance services in order to reduce the burden of clerical
functions as well as capital expenditures.
This
report provides a detailed analysis of the global pharmacovigilance
market and assists in understanding various market regulating
factors. The market overview section in this report provides analysis
of the overall market trends and market dynamics such as market
driving factors, restraining factors, and opportunities, which
currently administrate the dynamics of the overall pharmacovigilance
market. Additionally, the segment also provides and predicts the
future circumstances of the market. Market monitoring tools such as
Porter’s five forces analysis is also included in this study to
provide analysis about the competition in the pharmacovigilance
market and market attractiveness in various regions across the world.
Competitive analysis tools such as market share analysis and market
attractive analysis have also been included in the market overview
section of the report to deliver a comprehensive status of the
players in the global pharmacovigilance market. The executive summary
provided in this report reflects the highlights of the study scope
and the overall market in a summarized form. Furthermore, it includes
a market snapshot, which provides a glance at the current scenario of
the global pharmacovigilance market in terms of current and future
market size and growth.
Request
for sample report
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1729
The
global pharmacovigilance market is segmented on the basis of clinical
trial phases, type of methods, service providers, and geography.
Based on clinical trial phases, the pharmacovigilance market is
segmented into preclinical studies, phase I trial, phase II trial,
phase III trial, and phase IV trial (post marketing surveillance).
Based on the methods, this study segments the market into spontaneous
reporting, targeted reporting, cohort event monitoring, Intensified
ADR, and Reporting EHR mining. Based on service providers, the global
pharmacovigilance market is categorized into in-house and contract
outsourcing. The market size estimations for the period from 2012 to
2020 have been provided for each segment in terms of USD million.
Compounded annual growth rates (CAGR %) for each segment has been
provided for the period between 2014 and 2020, considering 2013 as
the base year.
In
terms of regional analysis, the global pharmacovigilance market has
been segmented into four key geographies: North America, Europe, Asia
Pacific, and Rest of World (RoW). Market revenue estimations for each
of these geographies have been provided in the report for the period
from 2012 to 2020 in terms of USD million, considering 2013 as the
base year for calculations and 2012 as the historical year. The CAGR
(%) of each market segment for the forecast period from 2014 to 2020
has also been provided along with market size estimations. This study
also provides recommendations for players of the global
pharmacovigilance market, which include aspects that may play a
decisive role in improving the market share.
Browse
Press Release Pharmacovigilance Market
http://www.transparencymarketresearch.com/pressrelease/global-pharmacovigilance-market.htm
The
report concludes with in-depth profiles of leading players, which
include key information about the major organizations dynamically
involved in the global pharmacovigilance market. The report profiles
the key market players in terms of company overview, financial
overview, product portfolio, business strategies, and recent
developments. The key companies profiled in this study are Accenture,
Plc, Clinquest Group B.V., Cognizant Technology Solutions, Covance,
Inc. ICON, Plc, iMED Global Corporation, inVentiv Health, Inc.,
Parexel International Corporation, Pharmaceutical Product Development
LLC, PRA Health Sciences, Inc., Quintiles Transnational Holdings Inc,
F. Hoffmann-La Roche Ltd., Sanofi , Synowledge LLC, Wipro Limited.
Market share analysis of the organizations operating in the
pharmacovigilance market would help new entrants to understand key
business policies and identify product portfolio of established
companies.
The
global pharmacovigilance market is segmented as follows:
Pharmacovigilance
Market, by Phases of Drug Development
- Preclinical Studies
- Phase I
- Phase II
- Phase III
- Phase IV or Post Marketing Surveillance
Pharmacovigilance
Market, by Type of Methods
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
Pharmacovigilance
Market, by Type of Service
- In-House
- Contract Outsourcing
Pharmacovigilance
Market, by Geography
- North America
- Europe
- Asia Pacific
- Rest of the World (RoW)
Browse
All Healthcare IT Market Research Reports @
http://www.transparencymarketresearch.com/healthcareit-market-reports-19.html
About
Us
Transparency
Market Research (TMR) is a global market intelligence company
providing business information reports and services. The company’s
exclusive blend of quantitative forecasting and trend analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants
use proprietary data sources and various tools and techniques to
gather and analyze information.
TMR’s
data repository is continuously updated and revised by a team of
research experts so that it always reflects the latest trends and
information. With extensive research and analysis capabilities,
Transparency Market Research employs rigorous primary and secondary
research techniques to develop distinctive data sets and research
material for business reports.
Contact
:
Mr.
Nachiket
State
Tower,
90
State Street,
Suite
700,
Albany
NY - 12207
United
States
Tel:
+1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
No comments:
Post a Comment